Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sutro Biopharma stock | $18.65

Learn how to easily invest in Sutro Biopharma stock.

Sutro Biopharma, Inc
+$0.20 (+1.13%)

Sutro Biopharma, Inc is a biotechnology business based in the US. Sutro Biopharma shares (STRO) are listed on the NASDAQ and all prices are listed in US Dollars. Sutro Biopharma employs 195 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Sutro Biopharma

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – STRO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Sutro Biopharma stock price (NASDAQ: STRO)

Use our graph to track the performance of STRO stocks over time.

Sutro Biopharma shares at a glance

Information last updated 2021-07-28.
Latest market close$18.65
52-week range$7.77 - $28.30
50-day moving average $18.32
200-day moving average $21.06
Wall St. target price$32.29
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.44

Buy Sutro Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sutro Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sutro Biopharma price performance over time

Historical closes compared with the close of $18.65 from 2021-06-08

1 week (2021-07-24) N/A
1 month (2021-07-02) -0.96%
3 months (2021-05-04) -3.92%
6 months (2021-01-31) N/A
1 year (2020-07-31) N/A
2 years (2019-07-31) N/A
3 years (2018-07-31) N/A
5 years (2016-07-31) N/A

Sutro Biopharma financials

Revenue TTM $50.2 million
Gross profit TTM $-34,239,000
Return on assets TTM -17.27%
Return on equity TTM -22.03%
Profit margin -85.39%
Book value $6.67
Market capitalisation $807.7 million

TTM: trailing 12 months

Shorting Sutro Biopharma shares

There are currently 3.0 million Sutro Biopharma shares held short by investors – that's known as Sutro Biopharma's "short interest". This figure is 3.5% down from 3.1 million last month.

There are a few different ways that this level of interest in shorting Sutro Biopharma shares can be evaluated.

Sutro Biopharma's "short interest ratio" (SIR)

Sutro Biopharma's "short interest ratio" (SIR) is the quantity of Sutro Biopharma shares currently shorted divided by the average quantity of Sutro Biopharma shares traded daily (recently around 467212.93375394). Sutro Biopharma's SIR currently stands at 6.34. In other words for every 100,000 Sutro Biopharma shares traded daily on the market, roughly 6340 shares are currently held short.

However Sutro Biopharma's short interest can also be evaluated against the total number of Sutro Biopharma shares, or, against the total number of tradable Sutro Biopharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sutro Biopharma's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Sutro Biopharma shares in existence, roughly 60 shares are currently held short) or 0.0718% of the tradable shares (for every 100,000 tradable Sutro Biopharma shares, roughly 72 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Sutro Biopharma.

Find out more about how you can short Sutro Biopharma stock.

Sutro Biopharma share dividends

We're not expecting Sutro Biopharma to pay a dividend over the next 12 months.

Sutro Biopharma share price volatility

Over the last 12 months, Sutro Biopharma's shares have ranged in value from as little as $7.77 up to $28.3. A popular way to gauge a stock's volatility is its "beta".

STRO.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sutro Biopharma's is 0.7281. This would suggest that Sutro Biopharma's shares are less volatile than average (for this exchange).

Sutro Biopharma overview

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc.

Stocks similar to Sutro Biopharma

Frequently asked questions

What percentage of Sutro Biopharma is owned by insiders or institutions?
Currently 10.692% of Sutro Biopharma shares are held by insiders and 106.13% by institutions.
How many people work for Sutro Biopharma?
Latest data suggests 195 work at Sutro Biopharma.
When does the fiscal year end for Sutro Biopharma?
Sutro Biopharma's fiscal year ends in December.
Where is Sutro Biopharma based?
Sutro Biopharma's address is: 310 Utah Avenue, South San Francisco, CA, United States, 94080
What is Sutro Biopharma's ISIN number?
Sutro Biopharma's international securities identification number is: US8693671021
What is Sutro Biopharma's CUSIP number?
Sutro Biopharma's Committee on Uniform Securities Identification Procedures number is: 869367102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site